 |
|
Mitral Valve ReplacementStarr-Edwards Cloth-Covered Composite-Seat Prosthesis
W. Baker Allen, MD;
Robert B. Karp, MD;
Nicholas T. Kouchoukos, MD
AMA Arch Surg. 1974;109(5):642-647.
Abstract
One hundred thirty-nine patients had isolated mitral valve replacement with the Starr-Edwards model 6310-6320 prosthesis during a 48-month period. The hospital mortality was 5% (seven patients). There have been 15 late deaths (11%) in a follow-up period that averaged 16.8 months. Ten patients (7%) had thromboembolic episodes, of which three were fatal. Twelve patients (9%) had complications related to anticoagulant therapy and four died. There have been no prosthetic infections or hemolytic complications requiring transfusion or removal of the prosthesis. Mechanical malfunction of the model 6320 prosthesis has not been observed. The improved operative mortality and the decline in the late mortality and in valve-related complications with the model 6320 prosthesis suggest that valve replacement should be offered to symptomatic patients before substantial myocardial dysfunction has occurred.
Author Affiliations
From the Department of Surgery, University of Alabama School of Medicine, Birmingham, Ala.
Footnotes
Accepted for publication July 12, 1974.
Read before the 22nd scientific meeting of the International Cardiovascular Society, Chicago, June 21, 1974.
Reprint requests to Department of Surgery, University of Alabama School of Medicine, University Station, Birmingham, AL 35294 (Dr. Kouchoukos).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Late Re-operation for Aortic and Mitral Starr-Edwards Ball Valve Prostheses
Aoyagi et al.
Asian Cardiovasc. Thorac. Ann. 2006;14:467-471.
ABSTRACT
| FULL TEXT
Mitral Valve Replacement With the Hancock Stabilized Glutaraldehyde Valve: Clinical and Laboratory Evaluation
Buch et al.
Arch Surg 1975;110:1408-1415.
ABSTRACT
|
